Research & KnowledgeEvent: August 31, 2026
EIGEN Bio is working on integrating human molecular data, perturbation experiments, and mechanistic relationships across biological systems to inform drug discovery decisions.
Published
Signal category
Research & Knowledge
Quote
“That is the territory EIGEN Bio is working in.”
— EIGEN Bio team
Company
EIGEN Bio
Decoding cellular regulation into actionable drug insights
- Industry
- Biotechnology Research
- Location
- San Francisco, US
- Company size
- 8 employees
EiEigen Bio is a causal therapeutic intelligence platform that uses RNA, perturbational biology, and AI to understand disease mechanisms, identify actionable therapeutic opportunities, and accelerate better decisions from discovery through clinical development.